Fluvoxamine Mediates Specific, Early, and Delayed SARS-CoV-2 Protection through Antioxidant and Cytoprotective Pathways via Sigma-1 Receptor Agonism.
作者信息
Papadopoulos Konstantinos, Papadopoulou Alexandra, Aw Tar Choon
机构信息
THAI StemLife, 566/3 Soi Ramkhamhaeng 39 (Thepleela 1), Prachaouthit Rd., Wangthonglang, Wangthonglang, Bangkok 10310, Thailand.
Occupational and Environmental Health Services, Feelgood Lund, Ideon Science Park, Scheelevägen 17, 223 63 Lund, Sweden.
出版信息
Adv Pharm Bull. 2023 Jul;13(3):408-410. doi: 10.34172/apb.2023.045. Epub 2022 Sep 18.
Abstract
摘要
相似文献
1
Fluvoxamine Mediates Specific, Early, and Delayed SARS-CoV-2 Protection through Antioxidant and Cytoprotective Pathways via Sigma-1 Receptor Agonism.
Adv Pharm Bull. 2023 Jul;13(3):408-410. doi: 10.34172/apb.2023.045. Epub 2022 Sep 18.
2
Potentiation of nerve growth factor-induced neurite outgrowth by fluvoxamine: role of sigma-1 receptors, IP3 receptors and cellular signaling pathways.
PLoS One. 2008 Jul 2;3(7):e2558. doi: 10.1371/journal.pone.0002558.
3
Cognition and depression: the effects of fluvoxamine, a sigma-1 receptor agonist, reconsidered.
Hum Psychopharmacol. 2010 Apr;25(3):193-200. doi: 10.1002/hup.1106.
4
Highly Specific Sigma Receptor Ligands Exhibit Anti-Viral Properties in SARS-CoV-2 Infected Cells.
Pathogens. 2021 Nov 20;10(11):1514. doi: 10.3390/pathogens10111514.
5
Repurposing of CNS drugs to treat COVID-19 infection: targeting the sigma-1 receptor.
Eur Arch Psychiatry Clin Neurosci. 2021 Mar;271(2):249-258. doi: 10.1007/s00406-020-01231-x. Epub 2021 Jan 5.
6
Can the sigma-1 receptor agonist fluvoxamine prevent schizophrenia?
CNS Neurol Disord Drug Targets. 2009 Dec;8(6):470-4. doi: 10.2174/187152709789824633.
7
Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence.
Drugs. 2021 Dec;81(18):2081-2089. doi: 10.1007/s40265-021-01636-5. Epub 2021 Dec 1.
8
σ1-Receptor Agonism Protects against Renal Ischemia-Reperfusion Injury.
J Am Soc Nephrol. 2017 Jan;28(1):152-165. doi: 10.1681/ASN.2015070772. Epub 2016 Apr 7.
9
Beneficial effects of the sigma-1 agonist fluvoxamine for tardive dyskinesia in patients with postpsychotic depressive disorder of schizophrenia: report of 5 cases.
Prim Care Companion CNS Disord. 2012;14(6). doi: 10.4088/PCC.12br01401. Epub 2012 Nov 8.
10
Fluvoxamine enhances prefrontal dopaminergic neurotransmission in adrenalectomized/castrated mice via both 5-HT reuptake inhibition and σ(1) receptor activation.
Psychopharmacology (Berl). 2011 Oct;217(3):377-86. doi: 10.1007/s00213-011-2293-5. Epub 2011 Apr 13.
本文引用的文献
1
Fluvoxamine for Outpatient Management of COVID-19 to Prevent Hospitalization: A Systematic Review and Meta-analysis.
JAMA Netw Open. 2022 Apr 1;5(4):e226269. doi: 10.1001/jamanetworkopen.2022.6269.
2
Anti-SARS-CoV-2 Action of 5α-Reductase Inhibitors May Be Mediated by Dehydroepiandrosterone. Letter.
J Urol. 2022 May;207(5):1163-1164. doi: 10.1097/JU.0000000000002469. Epub 2022 Feb 4.
3
Sigma-1 Receptor Alleviates Airway Inflammation and Airway Remodeling Through AMPK/CXCR4 Signal Pathway.
Inflammation. 2022 Jun;45(3):1298-1312. doi: 10.1007/s10753-022-01621-4. Epub 2022 Jan 14.
4
Mechanisms of action of fluvoxamine for COVID-19: a historical review.
Mol Psychiatry. 2022 Apr;27(4):1898-1907. doi: 10.1038/s41380-021-01432-3. Epub 2022 Jan 7.
5
Mortality Risk Among Patients With COVID-19 Prescribed Selective Serotonin Reuptake Inhibitor Antidepressants.
JAMA Netw Open. 2021 Nov 1;4(11):e2133090. doi: 10.1001/jamanetworkopen.2021.33090.
6
Anti-SARS-CoV-2 Action of Fluvoxamine may be Mediated by Endothelial Nitric Oxide Synthase.
Pharmacopsychiatry. 2022 Jan;55(1):57. doi: 10.1055/a-1641-0357. Epub 2021 Sep 23.
7
Ethyl ferulate protects against lipopolysaccharide-induced acute lung injury by activating AMPK/Nrf2 signaling pathway.
Acta Pharmacol Sin. 2021 Dec;42(12):2069-2081. doi: 10.1038/s41401-021-00742-0. Epub 2021 Aug 20.
8
An Overview of NO Signaling Pathways in Aging.
Molecules. 2021 Jul 27;26(15):4533. doi: 10.3390/molecules26154533.
9
Soluble Angiotensin Converting Enzyme 2 (ACE2) Is Upregulated and Soluble Endothelial Nitric Oxide Synthase (eNOS) Is Downregulated in COVID-19-induced Acute Respiratory Distress Syndrome (ARDS).
Pharmaceuticals (Basel). 2021 Jul 19;14(7):695. doi: 10.3390/ph14070695.
10
Observational Study of Chlorpromazine in Hospitalized Patients with COVID-19.
Clin Drug Investig. 2021 Mar;41(3):221-233. doi: 10.1007/s40261-021-01001-0. Epub 2021 Feb 9.
Zotero 插件